Our work exemplifies how re-reactivation of this pathway in cardiac macrophages in adults improves post-MI outcomes and implies that activation of IL-13 signaling to macrophages could be developed as a therapeutic strategy for treating ischemic HF in humans. Here, IL13 is linked to myocardial infarction.